Particle.news

Download on the App Store

States Step In on Vaccine Guidance as CDC Chief Considers ACIP’s September Changes

Regional coalitions are issuing joint recommendations to preserve access during the federal review period.

Overview

  • ACIP kept COVID-19 vaccination for everyone 6 months and older under shared clinical decision making with no prescription required, recommended separate MMR and varicella doses before age 4, and left the hepatitis B birth dose unchanged while reaffirming universal prenatal HBV testing.
  • The recommendations require sign‑off by acting CDC director Jim O’Neill before taking formal effect, and clinicians are being told to plan for typical ordering needs with a possible supply pinch as use shifts away from MMRV.
  • Coverage through Vaccines for Children, Medicare, Medicaid, and commercial insurers is expected to continue without new prescription requirements, according to clinical and payer reporting.
  • Experts warn near‑term implementation will be uneven across pharmacy chains, payers, and states, and clinicians are emphasizing counseling for high‑risk groups and during pregnancy.
  • States are moving on their own: West Coast and Northeast blocs have issued broader joint guidance and coordination plans to maintain access, while Florida is advancing a rollback of childhood vaccine requirements, deepening a patchwork of policies.